- Case Report
- Open Access
Myotonic dystrophy type 1 presenting with stroke-like episodes: a case report
BMC Research Notesvolume 6, Article number: 243 (2013)
It is well known that myotonic dystrophy type 1 (DM1) - Curschmann-Steinert disease - is associated with white matter lesions in the brain. Further, DM1 patients may suffer from cardiac involvement and cardioembolic strokes. We report on the unique case of an adult-onset DM1 without cardiac or vascular abnormalities presenting with stroke-like episodes.
A 40 y old white female was admitted twice to our stroke unit with apoplectic dizziness, nausea, headaches, and numbness in the right arm. She was suffering from type 2 diabetes, cataract, and endometriosis. Magnetic resonance imaging (MRI) revealed confluent white matter lesions in all cerebral lobes. There was no hyperintensity on diffusion-weighted imaging (DWI) and no gadolinium enhancement. Cerebrospinal fluid was normal. Surprisingly, myotonic discharges were detected in electromyography (EMG). Genetic testing revealed 200 ± 10 CTG repeats in the dystrophia myotonica protein kinase (DMPK) gene on chromosome 19 and DM1 was diagnosed.
DM1 may be the cause of cerebral white matter lesions. This is the first case of DM1 presenting with stroke-like episodes.
Myotonic dystrophy type 1 (DM1, Curschmann-Steinert disease) is considered to be the most common adult-onset muscular dystrophy . In a European population, DM1 has an estimated prevalence of about 1:10.000 . DM1 is an autosomal-dominantly inherited disease caused by a trinucleotide (cytosine-thymine-guanine = CTG) expansion mutation in the dystrophia myotonica protein kinase (DMPK) gene on chromosome 19 . In DM1, the length of the mutation correlates with disease severity and age of onset . Phenotype includes myotonia, limb muscle weakness, muscle atrophy, facial weakness, ptosis, and multi-organ involvement including cataracts, insulin resistance, elevated liver enzyme levels, male hypogonadism and cardiac conduction defects . DM1 may also present with peripheral nervous manifestation (polyneuropathy) .
There are various cardiac manifestations in DM1 associated with high cardiac morbidity and mortality: atrioventricular block, ventricular premature contractions, atrial fibrillation/flutter, right/left bundle branch block, non-sustained ventricular tachycardia, sudden cardiac death, mitral valve prolaps, and left ventricular systolic dysfunction [7, 8]. Due to atrial fibrillation/flutter DM1 patients may suffer cardioembolic strokes but the incidence of cerebral infarctions is quite low (1.5% in a 17 y observation period) .
Myotonic dystrophy type 2 (proximal myotonic myopathy = PROMM) may be associated with stroke-like episodes . However, among DM1 patients no stroke-like symptoms have been reported, yet.
We report on a 40 y old white female admitted twice to our stroke unit (June and October 2012) because of apoplectic dizziness, nausea, headaches, and numbness in the right arm. In addition, the patient was suffering from type 2 diabetes, cataract, and endometriosis.
In the clinical neurological examination, there was a facial but no limb muscle weakness or atrophy. Ankle jerks were weak. Symptoms significantly improved after a couple of days.
Cranial computertomography showed numerous periventricular hypodense lesions without signs of acute cerebral infarction. Magnetic resonance imaging (MRI) was performed twice revealing general brain atrophy and multiple white matter lesions in all cerebral lobes, including the temporal region (Figures 1 and 2). No gadolinium enhancement and no abnormalities in diffusion weighted images (DWI) were found. No progression of the white matter lesions was detected from June to October on MRI scans.
Cardiologic examinations (including 24 h electrocardiogram and electrocardiography) and vascular ultrasonography showed no abnormalities. A lumbar puncture was performed to exclude inflammatory diseases of the central nervous system. In lab tests, serum creatine kinase (CK 194 U/l), C-reactive protein (CRP 16.4 mg/l), and γ-glutamyltransferase (GGT 63 U/l) were slightly elevated. Low-density lipoprotein cholesterol (LDL) levels were elevated (210.6 mg/dl) while high densitiy lipoprotein (HDL) was low (24.0 mg/dl), and the patient was given simvastatin. HbA1c was 7.00%. There weren’t any other cardiovascular risk factors.
Electroneurography revealed a reduced nerve conduction velocity in the left sural nerve (35 m/s). In addition, we found a nerve block in the left peroneal nerve (fibula head). Somatosensory potentials of the right median nerve had a reduced amplitude (N20-P25 amplitude right 1.04 μV, left 3.23 μV) indicating an axonal damage. Electroneurography of the median nerve did not reveal any signs of carpal tunnel syndrome. P100-latencies of visually evoked potentials were delayed on both sides (P100 right 115 ms, left 111 ms). Surprisingly, electromyography of the anterior tibial muscle at rest showed many myotonic discharges (Figure 3).
On the basis of electromyography, genetic examination focusing on DM1 was initiated. There was a CTG-expansion of 200 ± 10 trinucleotides on one allele of the DMPK gene confirming diagnosis of DM1. The disease had been previously unknown to the family.
This is the first case report of DM1 presenting as stroke-like episodes. While strokes may occur in DM1 patients due to cardiac involvement, MRI did not show any signs of acute cerebral infarction in this particular case. There was an amplitude reduction in somatosensory evoked potentials of the right median nerve (on the side of numbness) indicating axonal cerebral damage. The disease had been previously unknown to the family and the patient had no typical DM1 symptoms like limb weakness or myotonia. Physicians should be aware that extensive white matter lesions and stroke-like episodes may be the only symptoms of myotonic dystrophy. However, the observation does not necessarily constitute a causal relation.
Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
Suominen T, Bachinski LL, Auvinen S, Hackman P, Baggerly KA, Angelini C, Peltonen L, Krahe R, Udd B: Population frequency of myotonic dystrophy: higher than expected frequency of myotonic dystrophy type 2 (DM2) mutation in Finland. Eur J Hum Genet. 2011, 19: 776-782.
Haper PS: Myotonic dystrophy – the clinical picture. Myotonic dystrophy. 2001, London: WB Saunders, 17-46. 3
Kassubek J, Juengling FD, Hoffmann S, Rosenbohm A, Kurt A, Jurkat-Rott K, Steinbach P, Wolf M, Ludolph AC, Lehmann-Horn F, Lerche H, Weber YG: Quantification of brain atrophy in patients with myotonic dystrophy and proximal myotonic myopathy: a controlled 3-dimensional magnetic resonance imaging study. Neurosci Lett. 2003, 348: 73-76.
Kornblum C, Reul J, Kress W, Grothe C, Amanatidis N, Klockgether T, Schröder R: Cranial magnetic resonance imaging in genetically proven myotonic dystrophy type 1 and 2. J Neurol. 2004, 251: 710-714.
Minnerop M, Weber B, Schoene-Bake JC, Roeske S, Mirbach S, Anspach C, Schneider-Gold C, Betz RC, Helmstaedter C, Tittgemeyer M, Klockgether T, Kornblum C: The brain in myotonic dystrophy 1 and 2: evidence for a predominant white matter disease. Brain. 2011, 134: 3530-3546.
Jakkani R, Jyoti S, Ahmed M, Thomas MM: Magnetic resonance imaging findings in adult-form myotonic dystrophy type 1. Singapore Med J. 2012, 53: 150-152.
Petri H, Vissing J, Witting N, Bundgaard H, Køber L: Cardiac manifestations of myotonic dystrophy type 1. Int J Cardiol. 2012, 160: 82-88.
Chaudhry SP, Frishman WH: Myotonic dystrophies and the heart. Cardiol Rev. 2012, 20: 1-3.
Biller J, Ionasescu V, Zellweger H, Adams HP, Schultz DT: Frequency of cerebral infarction in patients with inherited neuromuscular diseases. Stroke. 1987, 18: 805-807.
Hund E, Jansen O, Koch MC, Ricker K, Fogel W, Niedermaier N, Otto M, Kuhn E, Meinck HM: Proximal myotonic myopathy with MRI white matter abnormalities of the brain. Neurology. 1997, 48: 33-37.
The authors declare that they have no competing interests.
All authors were involved in diagnostics, interpretation of the patient data, and writing of the paper. JR performed the electromyography and found myotonic discharges leading to genetic testing for DM1. All authors read and approved the final manuscript.